Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 20, Issue 7, Pages 1787-1794Publisher
ELSEVIER SCIENCE INC
DOI: 10.1111/ajt.16000
Keywords
donors and donation; deceased; donors and donation; donor-derived infections; editorial; personal viewpoint; ethics; ethics and public policy; infection and infectious agents - viral; infectious disease; organ acceptance; organ procurement and allocation; organ transplantation in general
Categories
Ask authors/readers for more resources
In the context of a rapidly evolving pandemic, multiple organizations have released guidelines stating that all organs from potential deceased donors with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection should be deferred, including from otherwise medically eligible donors found to have mild or asymptomatic SARS-CoV-2 discovered on routine donor screening. In this article, we critically examine the available data on the risk of transmission of SARS-CoV-2 through organ transplantation. The isolation of SARS-CoV-2 from nonlung clinical specimens, the detection of SARS-CoV-2 in autopsy specimens, previous experience with the related coronaviruses SARS-CoV and MERS-CoV, and the vast experience with other common RNA respiratory viruses are all addressed. Taken together, these data provide little evidence to suggest the presence of intact transmissible SARS-CoV in organs that can potentially be transplanted, specifically liver and heart. Other considerations including ethical, financial, societal, and logistical concerns are also addressed. We conclude that, for selected patients with high waitlist mortality, transplant programs should consider accepting heart or liver transplants from deceased donors with SARS-CoV-2 infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available